|
US2013302272A1
|
|
Therapeutic agents for muscular dystrophy
|
|
EP2431047A1
|
|
G-csf for use in treating muscle injury
|
|
WO2009044787A1
|
|
Remedy for tendon rupture disease comprising tenomodulin as the active ingredient
|
|
JP2011231014A
|
|
Therapeutic agent for heart failure
|
|
WO2008150030A1
|
|
Method of inducing differentiation into myocardial cells using g-csf
|
|
EP1946765A1
|
|
Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient
|
|
CA2540135A1
|
|
Method of inducing the differentiation of stem cells into cardiomyocytes
|
|
CN1780636A
|
|
Combined use of G-CSF with angiogenetic factor
|
|
KR20060008870A
|
|
Combined use of g-csf with angiogenetic factor
|
|
JPS58211414A
|
|
Manufacture of surface board of case, bag and the like
|
|
JPS57187218A
|
|
Manufacture of case
|
|
JPS57178938A
|
|
Belt and its manufacturing method
|
